Gain Therapeutics Stock Price on May 9, 2024
| GANX Stock | USD 1.74 0.01 0.58% |
If you're considering investing in Gain Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gain Therapeutics stands at 1.74, as last reported on the 28th of November, with the highest price reaching 1.86 and the lowest price hitting 1.71 during the day. Gain Therapeutics is very risky given 3 months investment horizon. Gain Therapeutics holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.0% are justified by taking the suggested risk. Use Gain Therapeutics Risk Adjusted Performance of 0.0754, downside deviation of 7.2, and Market Risk Adjusted Performance of 0.6069 to evaluate company specific risk that cannot be diversified away.
At this time, Gain Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 1,436 in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 11.9 M in 2024. . At this time, Gain Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 3.55 in 2024, whereas Price To Sales Ratio is likely to drop 732.51 in 2024. Gain Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gain |
Sharpe Ratio = 0.1377
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GANX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.23 actual daily | 64 64% of assets are less volatile |
Expected Return
| 1.0 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Gain Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gain Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.1506 | Enterprise Value Ebitda (1.55) | Price Sales 925.9162 | Shares Float 24.2 M | Wall Street Target Price 7.4 |
Related Headline
Lantern Pharma Headline on 9th of May 2024
Lantern Pharma GAAP EPS of -0.51 misses by 0.08 by seekingalpha.com
Lantern Pharma reports disappointing Q1 financial results, with a GAAP EPS of -0.51 missing estimates by 0.08.
Gain Therapeutics Valuation on May 9, 2024
It is possible to determine the worth of Gain Therapeutics on a given historical date. On May 9, 2024 Gain was worth 2.65 at the beginning of the trading date compared to the closed value of 2.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Gain Therapeutics stock. Still, in general, we apply an absolute valuation method to find Gain Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Gain Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Gain Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.86 | 2.98 | 2.65 | 2.68 | 202,533 | |
05/09/2024 | 2.65 | 2.97 | 2.48 | 2.54 | 239,414 |
| 2.70 | 2.70 | 2.41 | 2.51 | 106,802 |
| Backtest Gain Therapeutics | | | Gain Therapeutics History | | | Gain Therapeutics Valuation | Previous | Next |
Gain Therapeutics Trading Date Momentum on May 9, 2024
| On May 10 2024 Gain Therapeutics was traded for 2.51 at the closing time. The top price for the day was 2.70 and the lowest listed price was 2.41 . The trading volume for the day was 106.8 K. The trading history from May 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.18% . The overall trading delta against the current closing price is 3.15% . |
Gain Therapeutics Fundamentals Correlations and Trends
By evaluating Gain Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Gain Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Gain financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Gain Therapeutics Stock history
Gain Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gain is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gain Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gain Therapeutics stock prices may prove useful in developing a viable investing in Gain Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13 M | 11.9 M | |
| Net Loss | -15.8 M | -15 M |
Gain Therapeutics Quarterly Net Working Capital |
|
Gain Therapeutics Stock Technical Analysis
Gain Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Gain Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Gain Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Gain Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Gain Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gain Therapeutics shares will generate the highest return on investment. By undertsting and applying Gain Therapeutics stock market strength indicators, traders can identify Gain Therapeutics entry and exit signals to maximize returns
Gain Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gain Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gain Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gain to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0754 | |||
| Jensen Alpha | 0.5151 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0729 | |||
| Treynor Ratio | 0.5969 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.